Back to Holocene Advisors, LP Holocene Advisors, LP

DNLIDNLI
10 quarters

Position history for Holocene Advisors, LPHolocene Advisors, LP's holdings in DENALI THERAPEUTICS INC

Holocene Advisors, LP holds 3.9M shares of DNLI (DENALI THERAPEUTICS INC), worth $100.4M as of 2026-Q2. The position was increased (+22.2% shares). DNLI represents 0.2% of Holocene Advisors, LP's portfolio.

Current Value

$100.4M

Current Shares

3.9M

Total Value Change

+$82.8M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.9M
+22.2%
$100.4M0.2%$25.72
43
2026-Q1
Increased
3.2M
+1.4%
$61.4M0.1%$20.02
36
2025-Q4
Increased
3.2M
+0.5%
$52.1M0.1%$16.41
35
2025-Q3
Increased
3.1M
+677.8%
$45.5M0.1%$14.52
56
2025-Q2
New
403,172
-
$5.6M0.0%$14.10
37
2025-Q1
Exited
0
-100.0%
$00.0%$14.78
0
2024-Q4
Increased
199,072
+104.3%
$4.1M0.0%$20.24
43
2024-Q3
Increased
97,447
+65.0%
$2.8M0.0%$29.43
38
2024-Q2
Decreased
59,042
-93.1%
$1.4M0.0%$23.22
0
2024-Q1
New
860,948
-
$17.7M0.1%$20.52
39

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used